aTyr Pharma (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, has closed an underwritten public offering of 4,235,294 shares of its common stock. According to the update, the shares were each sold at the public offering price of $4.25, resulting in approximately $18 million in proceeds for aTyr Pharma. In addition, aTyr Pharma has granted the underwriters a 30-day option to purchase up to an additional 635,294 shares of common stock in connection with the public offering. ROTH Capital Partners acted as lead manager for the offering.
To view the full press release, visit http://nnw.fm/i8YDX
About aTyr Pharma, Inc.
aTyr is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is ATYR1923, a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in interstitial lung diseases. For more information, visit the company’s website at www.aTyrPharma.com.
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork.